Open Access

What is the evidence for SGLT2 inhibitors in HF?

Topic: Chronic Heart Failure, Other
Sponsored by Boehringer Ingelheim & Eli Lilly

Congress Presentation

About the speaker

Professor Ileana Pina

Thomas Jefferson University, Philadelphia (United States of America)
39 presentations

3 more presentations in this session

Welcome and introduction.

Speaker: Professor J. Butler (Dallas, US)


SGLT2 inhibitors for HF treatments in 2022 - What do the guidelines tell us?

Speaker: Professor G. Rosano (London, GB)


Panel discussion.

Speaker: Professor S. Anker (Berlin, DE)


Access the full session

SGLT2 inhibitors in practice (part 1): what is the state of heart failure treatment in 2022?

Speakers: Professor I. Pina, Professor J. Butler, Professor G. Rosano, Professor S. Anker

About the event


ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb